Best-selling in Manuals & Resources
Save on Manuals & Resources
- £5.48Trending at £6.46
- £11.28Trending at £13.98
- £9.14Trending at £12.99
- £9.60Trending at £9.71
- £15.50Trending at £19.02
- £13.65Trending at £14.12
- £18.71Trending at £18.96
About this product
- Author(s)Patrick Arbuthnot
- PublisherElsevier Science Publishing Co Inc
- Date of Publication18/06/2015
- GenreMedicine: General
- Place of PublicationSan Diego
- Country of PublicationUnited States
- ImprintAcademic Press Inc
- Weight800 g
- Width191 mm
- Height235 mm
- Table Of Contents1. Essentials of Gene Therapy for Viral infections 2. Harnessing RNAi to silence Viral Gene Expression 3. Antiviral sequence-specific DNA binding proteins 4. Viral Gene Therapy Vectors 5. Nonviral vectors 6. Gene therapy for HBV infection 7. Gene therapy for HCV infection 8. Gene therapy for HIV infection 9. Gene therapy for respiratory and other viral infections 10. Gene therapy for hemorrhagic fever viruses 11. Gene transfer for vaccination against viral infection 12. Conclusion
- Author BiographyPatrick Arbuthnot is currently a personal professor and director of the Antiviral Gene Therapy Research Unit at the University of the Witwatersrand in Johannesburg, South Africa. After completing a medical degree and then a PhD, he carried out post-doctoral research on gene therapy for liver diseases at Necker Hospital in Paris. For more than ten years, his primary research focus has been on advancing gene silencing and gene editing technologies to develop improved treatment of chronic hepatitis B virus infection. In addition, he has worked on furthering methods of disabling genes of HIV-1, Rift Valley Fever virus and hepatitis C virus. Dr Arbuthnot has been an author of numerous publications and edited scientific books on topics related to antiviral gene therapy.
This item doesn't belong on this page.
Thanks, we'll look into this.